Medicinal chemistry in the era of big data

Drug Discovery Today: Technologies

Volumn 14, Issue , 2015, Pages 37-41

  Richter, Lars ^a   Ecker, Gerhard F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL ACTIVITY; EC50; HIGH THROUGHPUT SCREENING; IC50; MEDICINAL CHEMISTRY; PROTEIN STRUCTURE; PUBLIC-PRIVATE PARTNERSHIP; DRUG DEVELOPMENT; FACTUAL DATABASE; MEASUREMENT ACCURACY;

CHEMISTRY, PHARMACEUTICAL; DATA ACCURACY; DATABASES, FACTUAL; DRUG DISCOVERY;

EID: 84951908473     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2015.06.001     Document Type: Review

References (23)

1. M.R. Barnes, and et al. Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery Nat Rev Drug Discov 8 2009 701 708
2. D. Goldmann, and et al. Exploiting open data: a new era in pharmacoinformatics Future Med Chem 6 2014 503 514
3. A.J. Williams, and et al. Open PHACTS: semantic interoperability for drug discovery Drug Discov Today 17 2012 1188 1198
4. K. Azzaoui, and et al. Scientific competency questions as basis for the development of a semantically enriched Open Pharmacological Space Drug Discov Today 18 2013 843 852
5. A. Gaulton, and et al. ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res 40 D1 2012 D1100 D1107
6. B. Zdrazil, and et al. Annotating human P-glycoprotein bioassay data Mol Inf 31 2012 599 609
7. Y. Hu, and J. Bajorath Growth of ligand-target interaction data in ChEMBL is associated with increasing and activity measurement-dependent compound promiscuity J Chem Inf Mod 52 2012 2550 2558
8. D. Goldmann, and et al. Novel scaffolds for modulation of TRPV1 identified with pharmacophore modeling and virtual screening Future Med Chem 7 2015 243 256
9. F. Montanari, and G.F. Ecker BCRP inhibition - from data collection to ligand-based modeling Mol Inf 33 2014 322 331
10. 50) of an enzymatic reaction Biochem Pharmacol 22 1973 3099 3108
11. i data J Med Chem 55 2012 5165 5173
12. T. Kalliokoski Comparability of mixed IC50 data - a statistical analysis PLOS ONE 8 2013 e61007
13. B. Sidders, and et al. Precompetitive activity to address the biological data needs of drug discovery Nat Rev Drug Discov 13 2014 83 84
14. Y. Wang, and et al. An overview of the PubChem BioAssay resource Nucleic Acids Res 38 Suppl. 1 2010 D255 D266
15. J.L. Sharman, and et al. IUPHAR-DB: updated database content and new features Nucleic Acids Res 41 D1 2013 D1083 D1088
16. K.M. Morrissey, and et al. The UCSF-FDA TransPortal: a public drug transporter database Clin Pharmacol Ther 92 2012 545 546
17. F. Horn, and et al. GPCRDB information system for G protein-coupled receptors Nucleic Acids Res 31 2003 294 297
18. C. Knox, and et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs Nucleic Acids Res 39 Suppl. 1 2011 D1035 D1041
19. H.E. Pence, and A.J. Williams ChemSpider: an online chemical information resource J Chem Educ 87 2010 1123 1124 http://www.chemspider.com
20. A. Mullard European lead factory opens for business Nat Rev Drug Discov 12 2013 173 175
21. E. Sukkar Bound to work better - studying how long a drug stays bound to a receptor can help scientists develop more effective medicines Pharm J 293 2014
22. N. Ozawa, and et al. Transporter database, TP-Search: a web-accessible comprehensive database for research in pharmacokinetics of drugs Pharm Res 21 2004 2133 2134
23. A.J. Williams, J. Wilbanks, and S. Ekins Why open drug discovery needs four simple rules for licensing data and models PLoS Comput Biol 8 2012 e1002706